Search results
Aimin Xu is currently a Chair Professor jointly appointed by the Department of Medicine and the Department of Pharmacology & Pharmacy, and also the director for State Key Laboratory of Pharmaceutical Biotechnology (www.sklpb.hku.hk) at the University of Hong Kong.
Professor Aimin Xu is currently a Professor in the Department of Medicine, School of Clinical Medicine and also the director for State Key Laboratory of Pharmaceutical Biotechnology (www.sklpb.hku.hk) at the University of Hong Kong.
Ye D, Wang Y, Li H, Jia W, Man K, Lo CM, Wang Y, Lam KSL*, Xu A*. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1α-mediated antioxidant capacity in mice.
Aimin Xu. Department of Medicine, Department of Pharmacology and Pharmacy, the University of Hong Kong. Verified email at hku.hk. Obesity diabetes biomarker discovery adipocyte biology adipokines. Articles Cited by Public access. Title. ... PM Vanhoutte, Y Zhao, A Xu, SWS Leung. Circulation research 119 (2), 375-396, 2016. 417:
Xu Aimin-CV My laboratory also identified and characterized several other novel adipokines and hepatokines, including adipocyte fatty acid binding protein (A-FABP), FGF21, Angptl4 and lipocalin2.
The HKU Scholars Hub is the current research information system of The University of Hong Kong. As a key vehicle of HKU's Knowledge Exchange Initiative, The Hub aims to enhance the visibility of HKU authors and their research, and to foster opportunities for collaboration.
Aimin XU | Cited by 36,452 | of The University of Hong Kong, Hong Kong (HKU) | Read 711 publications | Contact Aimin XU
